INTRODUCTION
Neurofi bromatosis type 1 (NF1) is an autosomal-dominant disease caused by a single gene mutation and affects all ethnic groups [1] . The gene for NF1, NF1, was cloned on chromosome 17q11.2 and comprises 60 exons spanning 350 kb of genomic DNA [2] . The NF1 gene has a large molecular size, variable transcripts, and heterogeneous mutation types. To date, >1270 mutations have been associated with restricted recurrence (Human Gene Mutation Database; http://www.hgmd.org/). NF1 is the most commonly inherited neurological disorder, affecting 1 in 3500 births [1] . Clinically, it is characterized by café-aulait spots, skin freckling, small or plexiform neurofi bromas, and Lisch nodules. Other manifestations, such as scoliosis, macrocephaly, pseudoarthrosis, short stature, mental subnormality, and malignancies are present in a minority of patients [3] , among whom, NF1-associated vasculopathy is
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is intimately assocated with vasculopathy [6] [7] [8] .
Here, we present a Chinese family with NF1 in which 10 members (21 total) suffered from stroke, fatal cerebral vessel stenosis, and vessel lesions, including cerebral vessel and/or vertebral artery (VA) abnormalities.
MATERIALS AND METHODS

NF1 Family with Combined Vascular Lesions or Other
Abnormalities
The study was approved by the Xuan Wu Hospital of Capital Medical University, Beijing, and the subjects gave informed consent. All NF1 patients in this study satisfi ed the National Institutes of Health diagnostic criteria, and clinical details are available [9] . Patient IV-4 was the proband ( were the primary diagnoses.
There were 11 NF1 patients in the proband's family, four of whom had died (Fig. 1) . Interestingly, three of the deaths were due to stroke. Moreover, in these three NF1 patients, the ages at death were 54 years for the proband's grandfather, only 40 for the proband's father, and 47 for II-2 (a sister of the proband's father) ( DNA samples from the surviving NF1 patients (except for III-1) and 7 normal family members were used for PCR and denaturing high-performance liquid chromatography (DHPLC) analysis to search for NF1 gene mutations.
Vascular Detection
Routine transcranial Doppler sonography and ultrasonography in the carotid territory were carried out for every member in our study [10, 11] . Digital subtraction angiography (DSA) was used for some patients with cerebral vessel stenosis [12] .
Oligonucleotide Primers, PCR Optimization, and PCR
Amplifi cation
Primer sequences for PCR amplification of all 60 exons of the NF1 gene were as described elsewhere [13] [14] [15] [16] . To The PCR cycling was as described by Han [16] . The working procedure comprised an initial denaturation at 94°C for 4 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at a specifi c temperature (Supplementary Table   1 ) for each fragment for 30 s, extension at 72°C for 30 s, and a final extension at 72°C for 10 min. Amplification of an appropriately-sized PCR product was confi rmed on 2% agarose gels. An additional denaturation and re-annealing step was required after standard PCR amplification for heteroduplex formation prior to DHPLC [17] . Samples were denatured at 95°C for 5 min and then allowed to re-anneal for 30 min.
DHPLC Analysis
DHPLC was performed on a WAVE DNA fragment analysis system using a DNAsep column (Transgenomic) [18] .
Full details are available from the authors. In brief, the successful resolution of heteroduplexes from homoduplexes requires an elution gradient at a partially-denaturing temperature. At this temperature, only heteroduplexes are destabilized by the mismatched bases and are therefore slightly more melted than the homoduplexes, resulting in an earlier elution than the homoduplexes [16] . This special resolution temperature (Tr) can be predicted by the DHPLCMelt software (http://insertion.stanford.edu/melt. html). Re-annealed DNA duplexes (7 μL) were injected onto the column and eluted with a linear acetonitrile gradient at a fl ow rate of 0.9 mL/min, with a mobile phase consisting of a mixture of buffers A (0.1 mol/L TEAA and 1 mmol/L EDTA) and B (25% acetonitrile in 0.1 mol/L TEAA). When more than one Tr for a particular fragment was recommended by the DHPLCMelt software, each recommended Tr was applied to determine the optimum sensitivity. Depending on the melting domains predicted by the software, the use of one, two, or three Trs was required to allow the successful analysis of individual PCR fragments [16] .
Sequencing Analysis
PCR products displaying a heterozygous pattern were purified and sequenced with an ABI Prism 371 Genetic Analyzer (PE Applied Biosystems).
RESULTS
Vascular Lesions and Abnormalities in NF1 Patients
The vascular lesions and abnormalities found in the NF1 family are presented in Table 1 . Almost all of the NF1 patients had an abnormal distribution of the VA.
DSA images of cerebral vessel stenosis are presented in Fig. 2 . The results suggested that NF1 mutations in these NF1 patients may be related to vascular development.
Prospective Screening for NF1 Mutations by DHPLC
All 60 exons of the NF1 gene were screened by optimized DHPLC analysis of 13 samples (6 NF1 patients and 7
normal members of the family). An identical mutation, c.541C>T, was found in all six patients (Table 1, Fig. 3 ).
Furthermore, this distinct mutation (Q181X) in all patients suggested a relationship between the symptoms and the mutation. Q181X has only been reported in a screen of 169 unrelated NF1 patients by Griffiths [19] but has not been reported in any clinical study of this NF1 site. In addition, 3 new missense mutations (c.4144G>A, c.5306C>G and c.638T>G) were detected in 3 normal members of the family (Table 1 , Fig. 4 ). The signifi cance of these mutations needs further study. NF1 is probably the single most common dominant genetic disorder [20] . Neurological deficits that affect the central nervous system can result from cerebrovascular disease, tumors, and malformations, and can occur secondary to deformities of the skull and spine and from the pressure of neurofi bromas on the spinal cord [21] .
Neurofibromin, the product of the NF1 gene, is also expressed in the endothelial and smooth-muscle cells of blood vessels, suggesting that abnormal function might cause vasculopathy by impairing the response of these cells to growth suppressor signals [5, 20, 22] . The underlying pathophysiology of vasculopathy in NF1 is incompletely understood, and defective neurofibromin function in the cellular components of the blood vessel wall may play a role [5, 22] .
In this report, the patients demonstrated the classical skin manifestations of NF1 and an autosomal-dominant family history, which fulfi lled the NIH consensus criteria [9] .
The major physiological events in this Chinese family were multiple intracranial stenosis and an abnormal or circuitous VA, but examination also disclosed other arteriostenosis, aneurysm, kidney tumor, and dys-allelotaxis. Because these patients did not have any risk factors for stroke, such as diabetes mellitus, hypertension, and hyperlipidemia, NF1-associated cerebral vasculopathy was suspected.
NF1 Mutation and Cerebrovascular Stenosis and Abnormality
Thus far, whether there is a close link between the specifi c mutation and the vasculopathy remains unknown [5, 22] . It was important to this study that the participants were relatively centralized NF1 patients with cerebrovascular stenosis.
Thus, the Chinese family in our study allowed us to determine whether there was a specifi c mutation related to the vasculopathy. The use of DHPLC for mutation detection represents a signifi cant advance in the molecular diagnosis of NF1 [16] . The common mutation (Q181X, Fig. 3 ) in all of the NF1 patients with cerebral vasculopathy suggested that the nonsense mutation which results in a truncated protein is the genetic factor for the manifestations of vasculopathy associated with NF1. Although this mutation (Q181X) has been reported by Griffiths et al. (http://www.hgmd.org/) [19] , no further clinical data related to the mutation has been presented.
It is known that NF1 is caused by NF1 gene mutation, but the relationship between the mutation and the corresponding symptoms, such as the 3 missense mutations in normal members of the NF1 family (Table 1 , Fig. 4 ), remains unclear.
Mutation of NF1 as a Risk Factor for Ischemic Stroke
Stroke is the third most common cause of death and the most common cause of disability in developed countries.
About 80% of strokes are ischemic [23] . Non-modifiable risk factors (age, African and Asian race, male sex) and acquired risk factors (hypertension, cigarette smoking, diabetes, atrial fibrillation, and obesity) account for much of the risk of ischemic stroke [24] , yet, stroke risk remains insufficiently explained by these factors [23, 25] . In our report, the stroke deaths were all in patients 40-55 years old. Thus, not only may pediatric stroke be associated with NF1 [25] , but also middle-aged stroke without risk factors for vascular disease may be caused by NF1 mutation. Continuing the theme of gene-environment interaction, some findings suggest that chronic inflammation is an important contributor to NF1 mutation-associated arteriopathy [6, 7] . Although the trigger for converting from a state of asymptomatic vascular dysfunction and inflammation to the development of arteriopathy remains clinically unclear, in stroke patients without obvious causative factors, NF1 mutation may be one genetic factor that needs to be considered.
In conclusion, in this study, a Chinese NF1 family, who presented with a high incidence of cerebral vasculopathy compared to the normal members of the family, was analyzed. All of the NF1 patients had a common nonsense mutation (Q181X) of the NF1 gene. These results suggest that this gene mutation may be one genetic factor for cerebral vasculopathy without any evident risk factors for stroke.
SUPPLEMENTAL DATA
Supplemental data include one table and can be found online at http://www.neurosci.cn/epData.asp?id=135.
